# Clinical Trial to Evaluate the Efficacy and Safety of DW4902

> **NCT07319520** · PHASE2 · COMPLETED · sponsor: **Daewon Pharmaceutical Co., Ltd.** · enrollment: 71 (actual)

## Conditions studied

- Myoma of Uterus

## Interventions

- **DRUG:** DW4902 Placebo
- **DRUG:** DW4902 160mg
- **DRUG:** DW4902 240mg
- **DRUG:** DW4902 320mg

## Key facts

- **NCT ID:** NCT07319520
- **Lead sponsor:** Daewon Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-06
- **Primary completion:** 2024-11-11
- **Final completion:** 2024-11-11
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07319520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07319520, "Clinical Trial to Evaluate the Efficacy and Safety of DW4902". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07319520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*